Clinical Trial Update: Analgecine for the Treatment of Neuropathic Pain [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for Analgecine in neuropathic pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Pain

Drugs mentioned

• Analgecine

Snippet

Sponsor: VanWorld Pharmaceutical (Rugao) Company Limited | Conditions: Neuropathic Pain | Phase 3 | Status: COMPLETED